The Asia Pacific stem cell therapy market is poised for substantial growth in the coming years, with a projected compound annual growth rate (CAGR) of 10.29% between 2023 and 2031. This growth is expected to drive the market value up to US$ 3,420.05 Mn by 2031, following a successful revenue performance of US$ 1,453.61 Mn in 2022.
Global exosome research market was valued at US$ 174.94 million in 2022 and is anticipated to record a revenue of US$ 1,158.04 Million by 2031 at a CAGR of 24.4% over the forecast period of 2023 to 2031.
Asia Pacific desktop virtualization market generated revenue of US$ 2,902.85 million in 2022 and it is estimated to reach valuation of US$ 6,567.33 million by 2030 at a CAGR of 10.74% during the forecast period, 2023–2030.
India specialty drug distribution market generated a revenue of US$ 2,045.35 million in 2022 and is estimated to reach a valuation of US$ 5,997.7 million by 2031 at a CAGR of 12.93% during the forecast period 2023–2031.
Global micro-mobility market generated revenue of US$ 3,111.8 million in 2022 and is estimated to reach valuation of US$ 10,485.8 million by 2031 at a CAGR of 15.3% during the forecast period, 2023–2031.
The North America Terahertz Technology market is witnessing an unprecedented growth trajectory, with revenue projected to surge at a staggering CAGR of 38.4% between 2023 and 2031. As per the latest market report, the market generated revenue of US$ 272.65 Mn in 2022 and is expected to reach US$ 4,620.28 Mn by 2031.
ASEAN nutritional supplements market generated revenue of US$ 7,366.8 million in 2022 and it is estimated to reach valuation of US$ 14,847.3 million by 2031 at a CAGR of 8.4% during the forecast period, 2023–2031.
Australia hip and knee implants market was valued at US$ 552.0 Mn in 2022 and is estimated to reach a valuation of US$ 1,315.05 Mn by 2030 at a CAGR of 11.46% over the forecast period 2023-2030.